Condition: Coronary Artery Disease · Sponsor: Samsung Medical Center
A prospective, multi-center, open-label, randomized controlled, superiority trial. The aim of the study is to compare clinical outcomes between upfront 2-stenting strategy versus upfront drug-coated balloon (DCB)-based hybrid strategy in patients with complex coronary bifurcation with clinically relevant side branch lesions.
This description comes directly from the study's public registry record.
Young Bin Song, MD, PhD · 82-2-3410-2575 · youngbin.song@gmail.com
Joo Myung Lee, MD, MPH, PhD · 82-2-3410-2575 · drone80@hanmail.net
Always discuss trial participation with your own doctor first.
| Chonnam National University Hospital | Gwangju, South Korea | Not Yet Recruiting |
| Chosun University Hospital | Gwangju, South Korea | Not Yet Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019350